Search

Search Constraints

You searched for: Author/Creator Marek, Kenneth

Search Results

21. Dopamine transporter imaging predicts clinically‐defined α‐synucleinopathy in REM sleep behavior disorder. Issue 1 (15th December 2020)

22. Dopamine Transporter Neuroimaging as an Enrichment Biomarker in Early Parkinson's Disease Clinical Trials: A Disease Progression Modeling Analysis. Issue 1 (27th July 2017)

23. Early Clinical Predictors of Treatment‐Resistant and Functional Outcomes in Parkinson's Disease. Issue 1 (14th December 2015)

24. Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's Disease. Issue 3 (2nd July 2020)

25. IC‐P‐030: Comparison of reference regions for improved detection of change in florbetapir PET from phase 3 solanezumab trials. (1st July 2015)

26. IC‐P‐217: PRECLINICAL AND CLINICAL CHARACTERIZATION OF 18F‐PM‐PBB3, A PET LIGAND FOR DIVERSE TAU PATHOLOGIES. (1st July 2006)

27. IC‐P‐220: CLINICAL UPDATE: 18F‐PI‐2620, A NEXT GENERATION TAU PET AGENT EVALUATED IN SUBJECTS WITH ALZHEIMER'S DISEASE AND PROGRESSIVE SUPRANUCLEAR PALSY. (1st July 2006)

28. Longitudinal analyses of cerebrospinal fluid α‐Synuclein in prodromal and early Parkinson's disease. Issue 9 (30th July 2019)

29. Longitudinal Analysis of Multiple Neurotransmitter Metabolites in Cerebrospinal Fluid in Early Parkinson's Disease. Issue 8 (4th May 2021)

30. Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort. Issue 5 (23rd March 2018)